Lanzamiento Enero 2027

Ensayo controlado aleatorizado2008Financiación no declarada

Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status

Taes YE, Marescau B, De Vriese A, De Deyn PP, Schepers E, Vanholder R, Delanghe JR

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 25 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2007-01-08 · Nephrol Dial Transplant · vol. 23 · número 4 · págs. 1330–1335
Editorial
Oxford University Press
Citado
34 citas · más que el 80% de estudios similares · 1.1× el promedio de su campo
Referencias
35 trabajos
Acceso
De pago
Áreas de investigación
Dialysis and Renal Disease Management · Muscle metabolism and nutrition · Clinical Nutrition and Gastroenterology
Palabras clave
creatine supplementation, guanidino compounds, chronic kidney disease, hemodialysis, uremic toxins, guanidinoacetic acid, inflammation, C-reactive protein, serum urea
MeSH
humans, inflammation, guanidines, creatine, succinates, urea, arginine, glycine, c-reactive protein, prognosis, treatment outcome, renal dialysis, nephelometry and turbidimetry, administration, oral, severity of illness index, follow-up studies, cross-over studies, double-blind method, dose-response relationship, drug, aged, male, renal insufficiency, biomarkers

7 autores

  • Youri Taes🇧🇪 · autor de correspondenciaGhent University Hospital
  • Bart Marescau🇧🇪University of Antwerp; Institute Born-Bunge
  • An S. De Vriese
  • Peter Paul De Deyn🇧🇪University of Antwerp; Institute Born-Bunge
  • E. Schepers🇧🇪Ghent University Hospital
  • Raymond Vanholder🇧🇪Ghent University Hospital
  • Joris R. Delanghe🇧🇪Ghent University Hospital

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Specific guanidino compounds have been described as uraemic toxins and their concentrations are increased in renal failure due to dimished glomerular filtration, whereas the guanidino compound creatine is used as a performance-enhancing substance in athletes. The present study investigates the effects of creatine supplementation on plasma guanidino compounds in a chronic haemodialysis population.

Methods

Twenty male haemodialysis patients were included in a placebo-controlled cross-over trial. Patients were treated with creatine (2 g/day) or placebo during two treatment periods of 4 weeks, separated by a washout of 4 weeks. Plasma guanidino compounds and routine biochemical parameters were determined, as well as the prognostic inflammatory and nutritional index (PINI).

Results

Upon creatine supplementation, guanidinoacetate concentrations decreased by 15%, due to inhibition of creatine synthesis. Concentrations of alpha-keto-delta-guanidinovaleric acid increased three-fold and argininic acid concentrations doubled. Guanidinosuccinate concentrations did not change, but correlated inversely with CRP (r = -0.736; P = 0.001), PINI-score (r = -0.716; P = 0.002) and correlated positively with plasma urea concentration (r = 0.54; P = 0.02).

Conclusions

Creatine supplementation in haemodialysis patients significantly altered the concentration of specific guanidino compounds. Guanidinosuccinate correlated positively with plasma urea and negatively with inflammation markers.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.